Journal of Biological Chemistry
Volume 277, Issue 35, 30 August 2002, Pages 31491-31498
Journal home page for Journal of Biological Chemistry

MECHANISMS OF SIGNAL TRANSDUCTION
Activation of Retinoic Acid Receptor-dependent Transcription by All-trans-retinoic Acid Metabolites and Isomers*

https://doi.org/10.1074/jbc.M205016200Get rights and content
Under a Creative Commons license
open access

We have shown that four metabolites of all-trans-retinoic acid (ATRA) (4-oxo-, 4-OH-, 18-OH-, and 5,6-epoxy-RA) can induce maturation of NB4 promyelocytic leukemia cells (Idres, N., Benoit, G., Flexor, M. A., Lanotte, M., and Chabot, G. G. (2001) Cancer Res. 61, 700–705). To better understand the mechanism of action of ATRA metabolites and isomers, we assessed their binding to retinoic acid receptors (RARs) and activation of RAR-mediated transcription via a retinoic acid response element (RARE). Competition binding experiments with tritiated ATRA showed that all metabolites could bind to RARs with variable affinity. For transactivation studies, COS-7 cells were cotransfected with RARα, β, or γ expression vectors and the reporter plasmid RARE-tk-Luc, and the retinoid concentrations for half-maximal luciferase activity (EC50) were determined. All retinoids tested could activate the three RAR isotypes. The lowest EC50 value for RARα was with 9-cis-RA (13 nm), followed by 4-oxo-RA (33 nm), 5,6-epoxy-RA (77 nm), 13-cis-RA (124 nm), 18-OH-RA (162 nm), ATRA (169 nm), and 4-OH-RA (791 nm). For RARβ, the EC50 values increased as follows: 4-oxo-RA (8 nm), ATRA (9 nm), 18-OH-RA (14 nm), 5,6-epoxy-RA (35 nm), 13-cis-RA (47 nm), 4-OH-RA (64 nm), and 9-cis-RA (173 nm). For RARγ the EC50 values were: ATRA (2 nm), 5,6-epoxy-RA (4 nm), 18-OH-RA (14 nm), 13-cis-RA (36 nm), 9-cis-RA (58 nm), 4-oxo-RA (89 nm), and 4-OH-RA (94 nm). By comparing the -fold induction of luciferase activity, all retinoids tested were equipotent at transactivating RARE-tk-Luc whatever the RAR considered. However, the best induction of the transcription was obtained for RARα, which was 5-fold higher than for RARβ and 10-fold higher than for RARγ. In conclusion, these data show that ATRA metabolites can bind to and activate the three RARs with variable relative affinity but with similar efficacy. These results suggest that ATRA metabolites may activate several signaling pathways and probably play an important role in cellular physiology and cancer therapy.

Cited by (0)

Published, JBC Papers in Press, June 17, 2002, DOI 10.1074/jbc.M205016200

*

This work was supported in part by INSERM, CNRS, and the Association pour la Recherche sur le Cancer (ARC), Villejuif.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Supported by a studentship from the Ministère de l'Education Nationale de la Recherche et de la Technologie, and by the Fondation pour la Recherche Médicale, Paris.

§

Supported by a studentship from ARC, Villejuif.